1592U89 nucleoside reverse transcriptase inhibitor: Glaxo began an open-label compassionate use program in pediatric AIDS patients at risk for disease progressi

Glaxo Wellcome Inc., Research Triangle

Read the full 57 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE